SALIX PHARMACEUTICALS LTD Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-04-01: Reporting owner D ALONZO THOMAS; Form 4; Security Option to Buy Common Stock; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2015-04-01: Reporting owner KEANE WILLIAM P; Form 4; Security Option to Buy Common Stock; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2015-03-13: Reporting owner KEANE WILLIAM P; Form 4; Security Option to Buy Common Stock; Transaction Holding.
- 2015-02-04: Reporting owner D ALONZO THOMAS; Form 4; Security Option to Buy Common Stock; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-04-01 | D ALONZO THOMAS Director, Officer (Acting President and CEO) | 4 | Option to Buy Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $17.63 exercise price | 2015-04-03 | |
| 2015-04-01 | KEANE WILLIAM P Director | 4 | Option to Buy Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $17.63 exercise price | 2015-04-03 | |
| 2015-03-13 holding as of filing | KEANE WILLIAM P Director | 4 | Option to Buy Common Stock Derivative · Direct | Holding | 15,000 owned after | $17.63 exercise price | 2015-03-13 | |
| 2015-02-04 holding as of filing | D ALONZO THOMAS Director, Officer (Acting Chief Executive Officer) | 4 | Option to Buy Common Stock Derivative · Direct | Holding | 15,000 owned after | $17.63 exercise price | 2015-02-04 |